Cargando…
Current experimental methods to investigate the impact of specialized pro-resolving lipid mediators on Sjögren’s syndrome
Sjögren’s syndrome is a chronic inflammatory autoimmune disease characterized by diminished secretory function of the exocrine glands. Although extensive investigation has been done to understand Sjögren’s syndrome, the causes of the disease are as yet unknown and treatments remain largely ineffecti...
Autores principales: | dos Santos, Harim T., Nam, Kihoon, Gil, Diana, Yellepeddi, Venkata, Baker, Olga J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878840/ https://www.ncbi.nlm.nih.gov/pubmed/36713415 http://dx.doi.org/10.3389/fimmu.2022.1094278 |
Ejemplares similares
-
Predictive modeling of aspirin‐triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome
por: Yellepeddi, Venkata Kashyap, et al.
Publicado: (2019) -
A combination treatment of low-dose dexamethasone and aspirin-triggered resolvin D1 reduces Sjögren syndrome–like features in a mouse model
por: dos Santos, Harim Tavares, et al.
Publicado: (2023) -
Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
por: Philippe, Réginald, et al.
Publicado: (2018) -
Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
por: Chávez-Castillo, Mervin, et al.
Publicado: (2021) -
Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)